Dar Al-Shifa Pharmaceuticals Company

PLSE:PHARMACARE Stock Report

Market Cap: US$30.2m

Dar Al-Shifa Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Bassim Subhi Farah Nasr

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership45.0%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Bassim Subhi Farah Nasr

no data

Tenure

Mr. Bassim Subhi Farah Khoury Nasr serves as Executive Chairman, Chief Executive Officer and General Manager at Dar Al-Shifa Pharmaceuticals Company (formerly known as Dar Al-Shifa'a for the Manufacturing...